• 9 Jul, 2024

Biospace features Tallac Therapeutics as an antibody-drug conjugate (ADC) drug developer

• 24 Jun, 2024

Clarivate for Life Sciences & Healthcare highlights Tallac Therapeutics as one of the seven Companies to Watch that are revolutionizing antibody drug conjugates (ADCs).

• 3 Nov, 2023

Tallac Presents First Clinical Data for TAC-001 at SITC 2023

• 21 Oct, 2021

Tallac SITC 2021 Presentation

• 12 Apr, 2021

Tallac AACR 2021 Presentation

• 12 Mar, 2021

AACR 2021 presentation on preclinical data for TAC-001

• 5 Nov, 2020

SITC 2020 Presentation